{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-11795"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-11795","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Cornus officinalis extract activates the Keap1/Nrf2 pathway and delays T1D onset in the NOD mouse","abstract":"Type 1 diabetes (T1D) is an autoimmune disorder that results in the destruction of the insulin producing pancreatic β cells. The only therapeutic option following T1D clinical onset is exogenous insulin supplementation. At present, there is no cure for T1D and attempted interventional therapy has been focused on modulating the immune system. Few attempts have been pursued at preserving β cell function and survival. Here we provide a novel approach using extract from the fruit of the Cornus officinalis (CO) tree to preserve β cell function through the prevention of β cell stress. CO has been used in traditional Chinese medicine to treat several aliments with contemporary research demonstrating CO has a therapeutic effect in type 2 diabetes. My in vitro findings using a human pancreatic cell line demonstrate that CO induces a robust activation of the critical Keap1/Nrf2 antioxidant pathway and inhibit hydrogen peroxide induced cell death. To further extrapolate these findings, we then performed an in vivo analysis in which we treated the non-obese diabetic mouse (NOD) with an oral gavage of CO. We found that CO significantly delayed T1D onset, hyperglycemia, pancreatic insulitis and preserved c-peptide secretion indicating a preservation of β cell mass and function. Individual composition analysis was performed using HPLC and mass spectrometry to reveal specific fractions within CO are inducing the biological effects. Taken together, our study has demonstrated the therapeutic potential and mechanism of action for CO as an interventional therapy of T1D.","abstract_html":"Type 1 diabetes (T1D) is an autoimmune disorder that results in the destruction of the insulin producing pancreatic β cells. The only therapeutic option following T1D clinical onset is exogenous insulin supplementation. At present, there is no cure for T1D and attempted interventional therapy has been focused on modulating the immune system. Few attempts have been pursued at preserving β cell function and survival. Here we provide a novel approach using extract from the fruit of the Cornus officinalis (CO) tree to preserve β cell function through the prevention of β cell stress. CO has been used in traditional Chinese medicine to treat several aliments with contemporary research demonstrating CO has a therapeutic effect in type 2 diabetes. My in vitro findings using a human pancreatic cell line demonstrate that CO induces a robust activation of the critical Keap1/Nrf2 antioxidant pathway and inhibit hydrogen peroxide induced cell death. To further extrapolate these findings, we then performed an in vivo analysis in which we treated the non-obese diabetic mouse (NOD) with an oral gavage of CO. We found that CO significantly delayed T1D onset, hyperglycemia, pancreatic insulitis and preserved c-peptide secretion indicating a preservation of β cell mass and function. Individual composition analysis was performed using HPLC and mass spectrometry to reveal specific fractions within CO are inducing the biological effects. Taken together, our study has demonstrated the therapeutic potential and mechanism of action for CO as an interventional therapy of T1D.","abstract_has_math":false,"creators":["Fletcher, Justin D"],"institution":"University of South Florida","degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Biology (Cell Biology, Microbiology, Molecular Biology)","degree_department":null,"school":null,"contributors":["Brant Burkhardt, Ph.D.","Mark Atkinson, Ph.D.","Stanley Stevens, Ph.D.","Meera Nanjundan, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-06-19T07:00:00Z","date_published":"2024-06-19T07:00:00Z","updated_at":"2026-11-19T08:50:05Z","subjects":["ethnopharmacology","Keap1/Nrf 2","Type 1 Diabetes","Molecular Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/10508","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/10508","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-11795","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Brant Burkhardt, Ph.D.","Mark Atkinson, Ph.D.","Stanley Stevens, Ph.D.","Meera Nanjundan, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Fletcher, Justin D"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-06-19T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology (Cell Biology, Microbiology, Molecular Biology)"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["ethnopharmacology","Keap1/Nrf 2","Type 1 Diabetes","Molecular Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/10508"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Type 1 diabetes (T1D) is an autoimmune disorder that results in the destruction of the insulin producing pancreatic β cells. The only therapeutic option following T1D clinical onset is exogenous insulin supplementation. At present, there is no cure for T1D and attempted interventional therapy has been focused on modulating the immune system. Few attempts have been pursued at preserving β cell function and survival. Here we provide a novel approach using extract from the fruit of the Cornus officinalis (CO) tree to preserve β cell function through the prevention of β cell stress. CO has been used in traditional Chinese medicine to treat several aliments with contemporary research demonstrating CO has a therapeutic effect in type 2 diabetes. My in vitro findings using a human pancreatic cell line demonstrate that CO induces a robust activation of the critical Keap1/Nrf2 antioxidant pathway and inhibit hydrogen peroxide induced cell death. To further extrapolate these findings, we then performed an in vivo analysis in which we treated the non-obese diabetic mouse (NOD) with an oral gavage of CO. We found that CO significantly delayed T1D onset, hyperglycemia, pancreatic insulitis and preserved c-peptide secretion indicating a preservation of β cell mass and function. Individual composition analysis was performed using HPLC and mass spectrometry to reveal specific fractions within CO are inducing the biological effects. Taken together, our study has demonstrated the therapeutic potential and mechanism of action for CO as an interventional therapy of T1D."]},{"key":"dc:title","label":"Title","values":["Cornus officinalis extract activates the Keap1/Nrf2 pathway and delays T1D onset in the NOD mouse"]}]}],"canonical_facts":{"dc:contributor":["Brant Burkhardt, Ph.D.","Mark Atkinson, Ph.D.","Stanley Stevens, Ph.D.","Meera Nanjundan, Ph.D."],"dc:creator":["Fletcher, Justin D"],"dc:date":["2024-06-19T07:00:00Z"],"dc:description":["Type 1 diabetes (T1D) is an autoimmune disorder that results in the destruction of the insulin producing pancreatic β cells. The only therapeutic option following T1D clinical onset is exogenous insulin supplementation. At present, there is no cure for T1D and attempted interventional therapy has been focused on modulating the immune system. Few attempts have been pursued at preserving β cell function and survival. Here we provide a novel approach using extract from the fruit of the Cornus officinalis (CO) tree to preserve β cell function through the prevention of β cell stress. CO has been used in traditional Chinese medicine to treat several aliments with contemporary research demonstrating CO has a therapeutic effect in type 2 diabetes. My in vitro findings using a human pancreatic cell line demonstrate that CO induces a robust activation of the critical Keap1/Nrf2 antioxidant pathway and inhibit hydrogen peroxide induced cell death. To further extrapolate these findings, we then performed an in vivo analysis in which we treated the non-obese diabetic mouse (NOD) with an oral gavage of CO. We found that CO significantly delayed T1D onset, hyperglycemia, pancreatic insulitis and preserved c-peptide secretion indicating a preservation of β cell mass and function. Individual composition analysis was performed using HPLC and mass spectrometry to reveal specific fractions within CO are inducing the biological effects. Taken together, our study has demonstrated the therapeutic potential and mechanism of action for CO as an interventional therapy of T1D."],"dc:identifier":["https://digitalcommons.usf.edu/etd/10508"],"dc:subject":["ethnopharmacology","Keap1/Nrf 2","Type 1 Diabetes","Molecular Biology"],"dc:title":["Cornus officinalis extract activates the Keap1/Nrf2 pathway and delays T1D onset in the NOD mouse"],"thesis:degree_discipline":["Biology (Cell Biology, Microbiology, Molecular Biology)"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:50:05Z"}